遺伝子解析市場：技術、用途、エンドユーザー、製品タイプ、ワークフロー別-2025-2030年世界予測

遺伝子解析市場は、2023年に102億4,000万米ドルと評価され、2024年には109億4,000万米ドルに達すると予測され、CAGR 6.90％で成長し、2030年には163億4,000万米ドルに達すると予測されています。

遺伝子解析は、遺伝子の構造と機能を理解するためにDNA、RNA、タンパク質を研究するもので、ヘルスケア、農業、バイオテクノロジーの各分野で極めて重要な役割を担っており、個別化医療、疾病診断、作物改良のイノベーションを推進しています。精密医療の礎石として、個々の遺伝子プロファイルに基づいたオーダーメイドの治療アプローチを可能にしています。遺伝子解析の必要性は、遺伝子疾患に関する洞察を提供し、医薬品開発を促進し、農業生産物を最適化する能力から生じ、それによってヘルスケアと食糧安全保障の重要な課題に対処します。遺伝子解析の世界市場は、技術の進歩、ゲノム配列決定のコスト低下、研究開発への注目の高まりによって大きな影響を受けています。ゲノミクスの新興市場は、CRISPR技術や次世代シーケンシングなどの技術革新から大きな恩恵を受けると予想され、利害関係者がこれらの高成長分野に投資して足跡を拡大する機会を提供しています。しかし、市場は倫理的な懸念、データ・プライバシーの問題、遺伝子データの複雑性の高さといった課題に直面しており、これが普及の妨げとなっています。さらに、厳しい規制の枠組みや標準化されたプロトコルの欠如が市場成長の障害となっています。こうした課題にもかかわらず、包括的な遺伝子データベースや分析プラットフォームの開発を目的とした研究機関やヘルスケアプロバイダーとの共同研究を通じて、事業拡大の大きなチャンスがあります。大きな可能性を秘めたイノベーション分野には、バイオインフォマティクス、個別化遺伝子治療、合成生物学などがあり、これらは疾病予防と介入戦略におけるブレークスルーの触媒となることが期待されています。市場関係者は、AIと機械学習をデータ解析に活用し、ゲノミクスの予測モデルを改良することに注力すべきです。成長見通しを最大化するために、企業は規制状況を積極的にナビゲートし、コンプライアンスを確保し、遺伝子データ利用に関連する倫理的懸念に対処すべきです。これらの戦略的優先事項に集中することで、企業は将来のヘルスケアと農業のパラダイムを形成する上で、遺伝子解析の変革力を活用することができます。

市場力学：急速に進化する遺伝子解析市場の主要市場インサイトを公開

遺伝子解析市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 個別化ヘルスケアと標的治療における遺伝子解析の役割拡大
  • ゲノム研究および公衆衛生プログラムに対する政府の取り組みと資金援助
  • 遺伝子研究を促進する学術機関とバイオテクノロジー企業の連携
  • 家系や健康に関する知見を得るための消費者向け遺伝子検査サービスに対する消費者の関心の高まり
• 市場抑制要因
  • 遺伝子検査結果のばらつきや精度に関する懸念の高まり
  • 急速な技術進歩と主要企業間の激しい競争による市場参入障壁
• 市場機会
  • 作物改良と害虫抵抗性のための農業における遺伝子検査アプリケーションの拡大
  • 創薬および個別化治療計画のための遺伝子解析ツールの開発
  • 精密農業と持続可能な農業実践のための遺伝的洞察の活用
• 市場の課題
  • 遺伝子解析と既存のヘルスケアシステムとの統合の複雑さ、データの相互運用性の問題
  • 遺伝子解析分野の専門知識と労働力の限界が市場成長に影響

ポーターの5つの力：遺伝子解析市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、遺伝子解析市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：遺伝子解析市場における外部からの影響の把握

外部マクロ環境要因は、遺伝子解析市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析遺伝子解析市場における競合情勢の把握

遺伝子解析市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス遺伝子解析市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、遺伝子解析市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨遺伝子解析市場における成功への道筋を描く

遺伝子解析市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • パーソナライズされたヘルスケアと標的治療における遺伝子解析の役割の拡大
    • ゲノム調査と公衆衛生プログラムに対する政府の取り組みと資金援助
    • 遺伝子調査を促進する学術機関とバイオテクノロジー企業の連携
    • 祖先や健康に関する洞察を得るための消費者向け遺伝子検査サービスへの消費者の関心が高まっている
  • 抑制要因
    • 遺伝子検査結果のばらつきと正確性に関する懸念が高まる
    • 急速な技術進歩と主要プレーヤー間の熾烈な競合による市場参入障壁
  • 機会
    • 作物の改良と害虫抵抗性のための農業における遺伝子検査の応用の拡大
    • 創薬と個別化治療計画のための遺伝子解析ツールの開発
    • 精密農業と持続可能な農業実践のための遺伝学的知見の活用
  • 課題
    • 遺伝子解析と既存のヘルスケアシステムの統合の複雑さとデータの相互運用性の問題
    • 遺伝子解析の分野における専門知識と労働力が限られており、市場の成長に影響を与えている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 遺伝子解析市場：技術別

• キャピラリー電気泳動
• クリスパー
• 質量分析
• マイクロアレイ
• 次世代シーケンシング
• ポリメラーゼ連鎖反応
• ポリメラーゼ連鎖反応（PCR）
  • デジタルPCR
  • リアルタイムPCR
• シングルセルゲノミクス

第7章 遺伝子解析市場：用途別

• 農業遺伝学
• 動物遺伝学
• 臨床診断
  • がん診断
  • 遺伝性疾患診断
  • 感染症
• 法医学
• 製薬・バイオテクノロジー
• 調査

第8章 遺伝子解析市場：エンドユーザー別

• 診断検査室
• 法医学研究所
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• 研究センターおよび学術機関

第9章 遺伝子解析市場：製品別

• 機器
• 試薬・消耗品
• ソフトウェアとサービス

第10章 遺伝子解析市場サンプルタイプ別

• 血
• 骨
• 唾液
• 組織

第11章 遺伝子解析市場：ワークフロー別

• データ分析
• 事前シーケンス
• シーケンシング

第12章 南北アメリカの遺伝子解析市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の遺伝子解析市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの遺伝子解析市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. 23andMe, Inc.
• 2. Adaptive Biotechnologies Corporation
• 3. Agilent Technologies, Inc.
• 4. Beckman Coulter, Inc.
• 5. BGI Group
• 6. Bio-Rad Laboratories, Inc.
• 7. Eurofins Scientific
• 8. F. Hoffmann-La Roche Ltd.
• 9. Genewiz, Inc.
• 10. Genomic Health, Inc.
• 11. Guardant Health, Inc.
• 12. Illumina, Inc.
• 13. Invitae Corporation
• 14. Myriad Genetics, Inc.
• 15. Oxford Nanopore Technologies plc
• 16. Pacific Biosciences of California, Inc.
• 17. PerkinElmer, Inc.
• 18. Personalis, Inc.
• 19. QIAGEN N.V.
• 20. Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. GENETIC ANALYSIS MARKET RESEARCH PROCESS
• FIGURE 2. GENETIC ANALYSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENETIC ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. GENETIC ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. GENETIC ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENETIC ANALYSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENETIC ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENETIC ANALYSIS MARKET DYNAMICS
• TABLE 7. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SINGLE-CELL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY AGRICULTURAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY GENETIC DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY FORENSIC SCIENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY BONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 74. CANADA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. CANADA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 76. CANADA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. CANADA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 78. CANADA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. CANADA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. CANADA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CANADA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 84. MEXICO GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 116. CHINA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. CHINA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 118. CHINA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. CHINA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 120. CHINA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. CHINA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. CHINA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 123. CHINA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 124. INDIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. INDIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 126. INDIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. INDIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 128. INDIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. INDIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. INDIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. INDIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 132. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 134. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 140. JAPAN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 142. JAPAN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. JAPAN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 148. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 150. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 152. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 156. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 158. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 160. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 164. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 166. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 168. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 174. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 180. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 182. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 184. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 187. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 188. THAILAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. THAILAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 190. THAILAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. THAILAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 192. THAILAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. THAILAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. THAILAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 195. THAILAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 196. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 198. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 200. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 203. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 213. DENMARK GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. DENMARK GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 215. DENMARK GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. DENMARK GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 217. DENMARK GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. DENMARK GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. DENMARK GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 220. DENMARK GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 221. EGYPT GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. EGYPT GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 223. EGYPT GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. EGYPT GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 225. EGYPT GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. EGYPT GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. EGYPT GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 228. EGYPT GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 229. FINLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. FINLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 231. FINLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. FINLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 233. FINLAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. FINLAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. FINLAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 236. FINLAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 237. FRANCE GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. FRANCE GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 239. FRANCE GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. FRANCE GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 241. FRANCE GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. FRANCE GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 243. FRANCE GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 244. FRANCE GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 245. GERMANY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 246. GERMANY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 247. GERMANY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 248. GERMANY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 249. GERMANY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 250. GERMANY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 251. GERMANY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 252. GERMANY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 253. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 254. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 255. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 257. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 258. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 260. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 261. ITALY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 262. ITALY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 263. ITALY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. ITALY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 265. ITALY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. ITALY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 267. ITALY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 268. ITALY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 269. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 271. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 273. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 274. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 276. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 277. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 278. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 279. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 281. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 282. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 284. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 285. NORWAY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 286. NORWAY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 287. NORWAY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 288. NORWAY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 289. NORWAY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 290. NORWAY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 291. NORWAY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 292. NORWAY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 293. POLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 294. POLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 295. POLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 296. POLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 297. POLAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 298. POLAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 299. POLAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 300. POLAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 301. QATAR GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 302. QATAR GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 303. QATAR GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 304. QATAR GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 305. QATAR GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 306. QATAR GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 307. QATAR GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 308. QATAR GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 309. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 310. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 311. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 312. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 313. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 314. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 315. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 316. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 318. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 319. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 320. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 321. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 322. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 323. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 324. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 325. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 326. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 327. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 328. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 329. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 330. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 331. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 332. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 333. SPAIN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 334. SPAIN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 335. SPAIN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 336. SPAIN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 337. SPAIN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 338. SPAIN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 339. SPAIN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 340. SPAIN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 341. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 342. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 343. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 344. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 345. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 346. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 347. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 348. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 349. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 350. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
• TABLE 351. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 352. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 353. SWITZERLAND GENETIC ANALYSIS

The Genetic Analysis Market was valued at USD 10.24 billion in 2023, expected to reach USD 10.94 billion in 2024, and is projected to grow at a CAGR of 6.90%, to USD 16.34 billion by 2030.

Genetic analysis, which encompasses studying DNA, RNA, and proteins to understand genetic structures and functions, has a pivotal role across healthcare, agriculture, and biotechnology sectors, driving innovations in personalized medicine, disease diagnostics, and crop improvement. It serves as a cornerstone in precision medicine, enabling tailored therapeutic approaches based on individual genetic profiles. The necessity of genetic analysis arises from its ability to provide insights into genetic disorders, facilitate drug development, and optimize agricultural outputs, thereby addressing crucial healthcare and food security challenges. The global market for genetic analysis is influenced significantly by technological advancements, the decreasing cost of genome sequencing, and a rising focus on research and development. Emerging markets in genomics are expected to benefit greatly from innovations such as CRISPR technology and next-generation sequencing, offering opportunities for stakeholders to expand their footprints by investing in these high-growth areas. However, the market faces challenges such as ethical concerns, data privacy issues, and the high complexity of genetic data which can hinder widespread adoption. Additionally, stringent regulatory frameworks and a lack of standardized protocols pose obstacles to market growth. Despite these challenges, there are substantial opportunities for business expansion through collaborations with research institutions and healthcare providers, aimed at developing comprehensive genetic databases and analytics platforms. Innovation areas with vast potential include bioinformatics, personalized gene therapies, and synthetic biology, which promise to catalyze breakthroughs in disease prevention and intervention strategies. Market players should focus on leveraging AI and machine learning for data analysis to refine predictive models in genomics. To maximize growth prospects, companies should navigate the regulatory landscape proactively, ensuring compliance and addressing ethical concerns related to genetic data usage. By focusing on these strategic priorities, businesses can harness the transformative power of genetic analysis in shaping future healthcare and agricultural paradigms.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genetic Analysis Market

The Genetic Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expanding role of genetic analysis in personalized healthcare and targeted therapies
  • Government initiatives and funding support for genomic research and public health programs
  • Collaboration between academic institutions and biotech companies fostering genetic research
  • Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
• Market Restraints
  • Growing concerns regarding the variability and accuracy of genetic testing results
  • Barriers to market entry due to rapid technological advancement and intense competition among key players
• Market Opportunities
  • Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
  • Development of genetic analysis tools for drug discovery and personalized treatment plans
  • Utilization of genetic insights for precision farming and sustainable agricultural practices
• Market Challenges
  • Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
  • Limited expertise and workforce in the field of genetic analysis impacting market growth

Porter's Five Forces: A Strategic Tool for Navigating the Genetic Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genetic Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genetic Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genetic Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genetic Analysis Market

A detailed market share analysis in the Genetic Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genetic Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genetic Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genetic Analysis Market

A strategic analysis of the Genetic Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genetic Analysis Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc., BGI Group, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Genewiz, Inc., Genomic Health, Inc., Guardant Health, Inc., Illumina, Inc., Invitae Corporation, Myriad Genetics, Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California, Inc., PerkinElmer, Inc., Personalis, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Capillary Electrophoresis, CRISPR, Mass Spectrometry, Microarray, Next-Generation Sequencing, Polymerase Chain Reaction, Polymerase Chain Reaction (PCR), and Single-Cell Genomics. The Polymerase Chain Reaction (PCR) is further studied across Digital PCR and Real-Time PCR.
• Based on Application, market is studied across Agricultural Genetics, Animal Genetics, Clinical Diagnostics, Forensic Science, Pharmaceutical & Biotechnology, and Research. The Clinical Diagnostics is further studied across Cancer Diagnostics, Genetic Disease Diagnostics, and Infectious Diseases.
• Based on End User, market is studied across Diagnostic Laboratories, Forensic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic Institutions.
• Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
• Based on Sample Type, market is studied across Blood, Bone, Saliva, and Tissue.
• Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expanding role of genetic analysis in personalized healthcare and targeted therapies
    • 5.1.1.2. Government initiatives and funding support for genomic research and public health programs
    • 5.1.1.3. Collaboration between academic institutions and biotech companies fostering genetic research
    • 5.1.1.4. Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
  • 5.1.2. Restraints
    • 5.1.2.1. Growing concerns regarding the variability and accuracy of genetic testing results
    • 5.1.2.2. Barriers to market entry due to rapid technological advancement and intense competition among key players
  • 5.1.3. Opportunities
    • 5.1.3.1. Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
    • 5.1.3.2. Development of genetic analysis tools for drug discovery and personalized treatment plans
    • 5.1.3.3. Utilization of genetic insights for precision farming and sustainable agricultural practices
  • 5.1.4. Challenges
    • 5.1.4.1. Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
    • 5.1.4.2. Limited expertise and workforce in the field of genetic analysis impacting market growth
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genetic Analysis Market, by Technology

• 6.1. Introduction
• 6.2. Capillary Electrophoresis
• 6.3. CRISPR
• 6.4. Mass Spectrometry
• 6.5. Microarray
• 6.6. Next-Generation Sequencing
• 6.7. Polymerase Chain Reaction
• 6.8. Polymerase Chain Reaction (PCR)
  • 6.8.1. Digital PCR
  • 6.8.2. Real-Time PCR
• 6.9. Single-Cell Genomics

7. Genetic Analysis Market, by Application

• 7.1. Introduction
• 7.2. Agricultural Genetics
• 7.3. Animal Genetics
• 7.4. Clinical Diagnostics
  • 7.4.1. Cancer Diagnostics
  • 7.4.2. Genetic Disease Diagnostics
  • 7.4.3. Infectious Diseases
• 7.5. Forensic Science
• 7.6. Pharmaceutical & Biotechnology
• 7.7. Research

8. Genetic Analysis Market, by End User

• 8.1. Introduction
• 8.2. Diagnostic Laboratories
• 8.3. Forensic Laboratories
• 8.4. Hospitals & Clinics
• 8.5. Pharmaceutical & Biotechnology Companies
• 8.6. Research Centers & Academic Institutions

9. Genetic Analysis Market, by Product

• 9.1. Introduction
• 9.2. Instruments
• 9.3. Reagents & Consumables
• 9.4. Software & Services

10. Genetic Analysis Market, by Sample Type

• 10.1. Introduction
• 10.2. Blood
• 10.3. Bone
• 10.4. Saliva
• 10.5. Tissue

11. Genetic Analysis Market, by Workflow

• 11.1. Introduction
• 11.2. Data Analysis
• 11.3. Pre-Sequencing
• 11.4. Sequencing

12. Americas Genetic Analysis Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Genetic Analysis Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Genetic Analysis Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 23andMe, Inc.
• 2. Adaptive Biotechnologies Corporation
• 3. Agilent Technologies, Inc.
• 4. Beckman Coulter, Inc.
• 5. BGI Group
• 6. Bio-Rad Laboratories, Inc.
• 7. Eurofins Scientific
• 8. F. Hoffmann-La Roche Ltd.
• 9. Genewiz, Inc.
• 10. Genomic Health, Inc.
• 11. Guardant Health, Inc.
• 12. Illumina, Inc.
• 13. Invitae Corporation
• 14. Myriad Genetics, Inc.
• 15. Oxford Nanopore Technologies plc
• 16. Pacific Biosciences of California, Inc.
• 17. PerkinElmer, Inc.
• 18. Personalis, Inc.
• 19. QIAGEN N.V.
• 20. Thermo Fisher Scientific Inc.